LASCO, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 3.693
EU - Europa 3.199
AS - Asia 1.047
SA - Sud America 9
AF - Africa 6
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.957
Nazione #
US - Stati Uniti d'America 3.675
IE - Irlanda 1.081
SE - Svezia 936
CN - Cina 796
IT - Italia 391
DE - Germania 233
FI - Finlandia 133
SG - Singapore 130
UA - Ucraina 124
FR - Francia 80
GB - Regno Unito 80
IN - India 62
PL - Polonia 62
BE - Belgio 27
HK - Hong Kong 26
CA - Canada 12
CZ - Repubblica Ceca 10
RU - Federazione Russa 10
NL - Olanda 9
CL - Cile 7
TR - Turchia 7
VN - Vietnam 7
CU - Cuba 6
JP - Giappone 5
CH - Svizzera 4
KR - Corea 4
AL - Albania 3
BG - Bulgaria 3
EG - Egitto 3
IQ - Iraq 3
IR - Iran 3
SN - Senegal 3
BR - Brasile 2
DK - Danimarca 2
ES - Italia 2
HU - Ungheria 2
NO - Norvegia 2
RO - Romania 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
Totale 7.957
Città #
Dublin 1.080
Chandler 781
Nyköping 514
Jacksonville 371
Beijing 286
Ashburn 207
Princeton 194
Dearborn 189
Medford 153
Ann Arbor 145
Messina 142
Cambridge 133
Bremen 124
Des Moines 117
Boardman 101
New York 90
Singapore 77
Jinan 66
Shenyang 57
Warsaw 57
Nanjing 50
San Mateo 48
Wilmington 46
Pune 41
Tianjin 41
Lancaster 36
Woodbridge 36
Hebei 28
Brussels 26
Haikou 26
Zhengzhou 25
Guangzhou 24
Hangzhou 24
Helsinki 24
Nanchang 23
Seattle 23
Houston 21
Los Angeles 21
Munich 21
Taizhou 21
Catania 20
Strasbourg 18
Ningbo 16
Fuzhou 15
Hyderabad 15
Jiaxing 14
Lanzhou 11
Taiyuan 11
Brno 10
Fremont 10
Rome 9
Changsha 8
Lentini 8
Milan 8
Central 7
Sheung Shui 7
Dong Ket 6
Fiumefreddo Di Sicilia 6
Leawood 6
Ottawa 6
Rende 6
Washington 6
Auburn Hills 5
Bydgoszcz 5
Clearwater 5
Redwood City 5
Turin 5
Aci Sant'antonio 4
Camagüey 4
Cosenza 4
Falls Church 4
Hefei 4
Istanbul 4
Norwalk 4
Amsterdam 3
Augusta 3
Caltagirone 3
Chengdu 3
Izmir 3
Milazzo 3
Piazza Armerina 3
Riva 3
Sheffield 3
Sofia 3
Archi 2
Ardabil 2
Birmingham 2
Brescia 2
Bronte 2
Budapest 2
Cave 2
Centuripe 2
Changle 2
Chaoyang 2
Chicago 2
Chieti 2
Ciudad Camilo Cienfuegos 2
Cupertino 2
Córdoba 2
Edinburgh 2
Totale 5.827
Nome #
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 94
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 88
Hyponatremia as a leading sign of hypopituitarism 87
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 87
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 85
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 84
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 83
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 82
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 82
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 81
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 81
null 78
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 78
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 73
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 71
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 71
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 70
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 69
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 69
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 68
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 67
Frailty and lipid profile in elderly hospitalized patients 67
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 66
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 66
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 65
IL-22 circulating serum levels in centenarians. 65
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 62
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 62
Serum anti-p53 autoantibodies in patients with type 1 diabetes 61
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 61
Sindrome di Cushing Subclinico in pazienti in postmenopausa con Osteoporosi 61
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 61
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 60
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 60
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 60
Relationship between blood pressure and frailty in older hypertensive outpatients 59
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 59
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 59
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 59
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 59
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 59
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 58
Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension 58
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 58
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 58
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 58
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 57
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 57
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 56
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 56
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 56
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 55
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 55
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 55
HEMOSTATIC VARIABLES IN ARTERIAL-HYPERTENSION 54
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 54
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 54
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 54
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 54
Stile di vita, invecchiamento e longevità 53
Somministrazione settimanale e giornaliera di alendronato nel trattamento dell'osteoporosi della thalassemia major. 53
Valutazione e comparazione del filtrato glomerulare stimato con due differenti formule in una popolazione di centenari 53
Vitamin D status and the relationship with bone fragility fractures in HIV-infected patients: A case control study 53
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 53
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 52
Anxiety levels as risk factor for osteoporosis in postmenopausal women 52
Disappearance of a virilizing adrenal tumor (VAT), in a woman who had been overtreated with nandrolone, by cyproterone acetate 51
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 51
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 51
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 51
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 51
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 51
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 51
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 51
Correction: In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia (Endocrine, (2019), 65, 3, (569-579), 10.1007/s12020-019-01908-x) 51
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 50
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 50
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 50
Sincope conseguente a severa depressione della conduzione atrio-ventricolare trattata con impianto di Pace-maker in un soggetto anziano affetto da fibrillazione atriale permanente e demenza in trattamento con rivastigmina 50
Long-term transdermal estrogen therapy improves lipid profile but not insulin resistance in healthy postmenopausal women 49
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 49
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. 49
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 49
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 49
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 49
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 49
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 49
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 48
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 48
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 48
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 48
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 48
Raloxifene and pituitary secretion in post-menopausal women 47
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 47
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 47
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 47
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 47
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 47
Subclinical hypercortisol-assessment of bone fragility: experience of single osteoporosis center in Sicily 47
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 46
Totale 5.921
Categoria #
all - tutte 35.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020915 0 0 11 50 14 182 119 99 43 225 137 35
2020/2021944 80 19 277 54 140 67 29 70 15 100 48 45
2021/20221.303 10 183 21 54 33 9 106 39 122 210 127 389
2022/20233.155 225 332 153 206 307 286 21 175 1.314 15 88 33
2023/2024811 62 135 34 107 57 189 19 58 6 27 12 105
2024/2025159 55 58 46 0 0 0 0 0 0 0 0 0
Totale 8.279